37 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2245503/are-medical-stocks-lagging-edwards-lifesciences-ew-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2245503
Mar 25, 2024 - Here is how Edwards Lifesciences (EW) and Avinger (AVGR) have performed compared to their sector so far this year.
zc:4255082120894007945
0
https://www.zacks.com/stock/news/2255450/will-elevance-elv-beat-q1-earnings-on-carelon-strength?cid=CS-ZC-FT-analyst_blog|earnings_preview-2255450
Apr 15, 2024 - The first-quarter results of Elevance (ELV) are likely to reflect higher product revenues and Commercial Individual membership growth.
zc:-2153811688991472951
0
https://www.zacks.com/stock/news/2257726/edwards-lifesciences-ew-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2257726
Apr 18, 2024 - Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:242527518149851865
0
https://www.zacks.com/stock/news/2258737/will-acute-care-unit-aid-universal-health-s-uhs-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258737
Apr 19, 2024 - Universal Health's (UHS) Q1 results are expected to be aided by growing patient volumes and surgical cases, partly offset by increased expenses.
zc:7175606925734299322
0
https://www.zacks.com/stock/news/2261581/watch-these-3-medtech-stocks-this-earnings-season-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2261581
Apr 24, 2024 - Here is a sneak peek into how the three major MedTech stocks, LH, EW and RMD, are expected to fare in their quarterly results slated to be released tomorrow.
zc:7835390946859946525
0
https://www.zacks.com/stock/news/2262802/compared-to-estimates-edwards-lifesciences-ew-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2262802
Apr 25, 2024 - Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:6489446814593803564
0
https://www.zacks.com/stock/news/2263589/factors-setting-the-tone-for-lantheus-lnth-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2263589
Apr 26, 2024 - Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.
zc:-5758547865263595747
0